153 related articles for article (PubMed ID: 16782729)
1. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
Watanabe K; Nomori H; Ohtsuka T; Naruke T; Ebihara A; Orikasa H; Yamazaki K; Uno K; Kobayashi T; Goya T
Jpn J Clin Oncol; 2006 Jul; 36(7):403-9. PubMed ID: 16782729
[TBL] [Abstract][Full Text] [Related]
2. 11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness.
Shibata H; Nomori H; Uno K; Iyama K; Tomiyoshi K; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
Ann Nucl Med; 2009 Sep; 23(7):609-16. PubMed ID: 19562438
[TBL] [Abstract][Full Text] [Related]
3. Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
Murakami S; Saito H; Sakuma Y; Mizutani Y; Ishikawa Y; Kondou T; Oshita F; Yokose T; Kameda Y; Suga Y; Ito H; Tsuboi M; Nakayama H; Noda K; Yamada K
Eur J Radiol; 2010 Aug; 75(2):e62-6. PubMed ID: 20005653
[TBL] [Abstract][Full Text] [Related]
4. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Kobayashi T; Uno K
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):396-401. PubMed ID: 15354098
[TBL] [Abstract][Full Text] [Related]
5. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
Nakamura H; Hirata T; Kitamura H; Nishikawa J
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
[TBL] [Abstract][Full Text] [Related]
8. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):70-3. PubMed ID: 19359282
[TBL] [Abstract][Full Text] [Related]
9. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
[TBL] [Abstract][Full Text] [Related]
10. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
Vesselle H; Salskov A; Turcotte E; Wiens L; Schmidt R; Jordan CD; Vallières E; Wood DE
J Thorac Oncol; 2008 Sep; 3(9):971-8. PubMed ID: 18758298
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
[TBL] [Abstract][Full Text] [Related]
12. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.
Ohtsuka T; Nomori H; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Cancer; 2006 Nov; 107(10):2468-73. PubMed ID: 17036361
[TBL] [Abstract][Full Text] [Related]
14. Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
Shimizu K; Hirami Y; Saisho S; Yukawa T; Maeda A; Yasuda K; Nakata M
Ann Thorac Surg; 2012 Feb; 93(2):398-403. PubMed ID: 22206958
[TBL] [Abstract][Full Text] [Related]
15. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
Hellwig D; Graeter TP; Ukena D; Georg T; Kirsch CM; Schäfers HJ
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):892-9. PubMed ID: 15573074
[TBL] [Abstract][Full Text] [Related]
16. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
Nomori H; Kosaka N; Watanabe K; Ohtsuka T; Naruke T; Kobayashi T; Uno K
Ann Thorac Surg; 2005 Dec; 80(6):2020-5. PubMed ID: 16305837
[TBL] [Abstract][Full Text] [Related]
17. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?
Buck AC; Schirrmeister HH; Guhlmann CA; Diederichs CG; Shen C; Buchmann I; Kotzerke J; Birk D; Mattfeldt T; Reske SN
J Nucl Med; 2001 May; 42(5):721-5. PubMed ID: 11337566
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors.
Nishii R; Saga T; Sudo H; Togawa T; Kuyama J; Tani T; Maeda T; Kobayashi M; Iizasa T; Shingyoji M; Itami M; Kawamura K; Hashimoto H; Yamazaki K; Tamura K; Higashi T
Ann Nucl Med; 2021 Feb; 35(2):211-222. PubMed ID: 33387282
[TBL] [Abstract][Full Text] [Related]
20. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
Ann Thorac Surg; 2005 Mar; 79(3):984-8; discussion 989. PubMed ID: 15734419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
